Halozyme
HALO
HALO
198 hedge funds and large institutions have $2.48B invested in Halozyme in 2017 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 72 increasing their positions, 54 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
18% more capital invested
Capital invested by funds: $2.11B → $2.48B (+$373M)
0.46% more ownership
Funds ownership: 85.64% → 86.1% (+0.46%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
198
Holding in Top 10
4
Calls
$62M
Puts
$24.9M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$18.2M | |
| 3 | +$14.9M | |
| 4 |
Millennium Management
New York
|
+$14.9M |
| 5 |
Two Sigma Advisers
New York
|
+$11.6M |
Top Sellers
| 1 | -$66.7M | |
| 2 | -$38.8M | |
| 3 | -$34.8M | |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$24.9M |
| 5 |
O
OrbiMed
New York
|
-$6.08M |